Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Ravi Salgia

Dr. Ravi Salgia

Medical Oncologist

Dr. Ravi Salgia is the associate director for clinical sciences at the City of Hope Comprehensive Cancer Center in Duarte, California.

Get in touch
Jump to a Topic:

About Ravi Salgia

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Research Excellence icon

    Excellence in Research

  • Team Leader icon

    Team Leader

  • 30+ Years of Experience icon

    30+ Years of Experience

  • Board Certified icon

    Board Certified in Medical Oncology

  • Board Certified icon

    Board Certified in Internal Medicine

Salgia has expertise in the treatment of pleural mesothelioma and lung cancer, focusing his research on the molecular mutations in those thoracic malignancies.

In his role at City of Hope Comprehensive Cancer Center, he doesn’t just treat the cancers. He works to create novel medicines to treat them more effectively.

Salgia has earned a reputation as a healer and an innovator. He was lured to City of Hope in 2016 by its innovative approach to advancing cancer therapies.

“City of Hope embodies the commitment to discovering new treatments that enhance quality of life for cancer patients,” Salgia said. “It is a privilege to work with a multidisciplinary team of physicians, nurse practitioners, scientists and other health professionals who are dedicated to providing the highest quality cancer treatment and care.”

Spent More Than a Decade in Chicago

Salgia worked for 12 years at the University of Chicago Comprehensive Cancer Center, where he served as associate director for translational sciences and director of the thoracic oncology program.

Salgia has been involved in research identifying cancer biomarkers that have become targets for new drugs. These biomarkers could be used someday to help doctors predict who is likely to get cancer or experience a recurrence after treatment.

Ravi Salgia M.D.

If you want to change the world, be that change.’ That’s [a quote] by Mahatma Gandhi, and I think it is what we have designed here at the University of Chicago.”

His research teams also have discovered certain proteins that make cancer drugs more potent. The enzyme tyrosine kinase, for example, is a protein which turns many cell functions on and off, becoming a key to lung cancer treatment.

Much of his research has been helped by City of Hope’s designation as a National Cancer Institute Comprehensive Cancer Center. That designation sparked research funding from the National Cancer Institute and American Cancer Society.

Doctor talking to patients

Talk to a Doctor About Your Diagnosis

We can help you or a loved one get in contact with Dr. Salgia and find the treatment that's best for you.

Get Started Today

Pioneers in Mesothelioma Treatment

Salgia has played a key role in expanding City of Hope’s clinical trial program, along with the integration of cutting-edge research with state-of-the-art therapeutics.

He also serves on various panels for the National Cancer Institute. He is co-chief editor for the Journal of Carcinogenesis and serves on the editorial advisory board of four additional journals.

Quick Fact:

Dr. Salgia is fluent in Hindi and Spanish.

Salgia treats thymic malignancies and bronchial carcinoids. He has helped pioneer the advancement of immunotherapy, which allows patients to use their own immune system to fight cancer.

With immunotherapy, patients often are spared many of the harsh side effects of cancer treatment.

“It was also figured, actually very intelligently, that you needed to supplement our patients with vitamins, like B-12 as well as folic acid, to have the maximal effect of the chemotherapy and have the minimal effect of the toxicity from this therapy itself,” he said.

Both a board-certified medical oncologist and internist, Salgia has been practicing medicine since 1987.

Salgia received his medical degree from Loyola University in Chicago. He did an internship and residency in internal medicine at The Johns Hopkins Hospital in Baltimore.

He completed another fellowship at the Dana-Farber Cancer Institute in Boston, where he also served as a clinical fellow at Harvard Medical School.

See More Top Mesothelioma Doctors

Dr. Salgia’s Publications

Salgia has written over 200 scholarly articles and contributed to 34 books related to thoracic diseases, including several involving mesothelioma. One of those articles explains the endothelial growth factor receptor in malignant pleural mesothelioma.

Disclaimer: Dr. Ravi Salgia has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. City of Hope. (2019, January 11). RAVI SALGIA, M.D., PH.D. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 7, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now